Instrumented assessment of muscle overactivity and spasticity with dynamic polyelectromyographic and motion analysis for treatment planning.
Esquenazi
Alberto
A
Department of Physical Medicine and Rehabilitation, Moss Rehab, Philadelphia, Pennsylvania 19141, USA.
Mayer
Nathaniel H
NH
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D004576:Electromyography / Q000379:methods; D004863:Equinus Deformity / Q000503:physiopathology; D005684:Gait / Q000502:physiology; D006801:Humans; D035002:Lower Extremity / Q000502:physiology; D016472:Motor Neuron Disease / Q000503:physiopathology*; D009128:Muscle Spasticity / Q000188:drug therapy / Q000503:physiopathology*; D009465:Neuromuscular Agents / Q000627:therapeutic use; D019148:Neuromuscular Blockade / Q000379:methods; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use; D019800:Phenol / Q000627:therapeutic use; D034941:Upper Extremity / Q000502:physiology
D009465:Neuromuscular Agents; D009466:Neuromuscular Blocking Agents; D019800:Phenol; D019274:Botulinum Toxins, Type A